8.35 USD
↗ 0.29 (3.60%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
8.38
↗ 0.03 (0.36%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
8.38
↗ 0.03 (0.36%)
Market: OPEN
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $8.38 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (104.2%) and a bullish Golden Cross on the moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 5, 2026.
Open?$8.15
High?$8.50
Low?$8.10
Prev. Close?$8.06
Volume?113.2K
Avg. Volume?191.3K
VWAP?$8.30
Rel. Volume?0.59x
Bid / Ask
Bid?$7.11 × 100
Ask?$9.42 × 100
Spread?$2.31
Midpoint?$8.27
Valuation & Ratios
Market Cap?236.8M
Shares Out?29.4M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.60
EPS?-$5.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
231.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.10Distress
Confidence?68%Moderate
Short InterestVery High
Short % of Float?15.97%High
Short Interest?1.9M
Days to Cover?12.3
Free Float12.1M
Avg Daily Volume156.5K
Settlement Date2026-07-15
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?7.44Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.60CHEAP▾
S&P97
P/S?133.42HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.3CHEAP▾
S&P97
EV/Sales?66.58HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?104.2%STRONG▾
Peers50
S&P97
ROA?-53.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-77374000
Enterprise Value?$118.2M
Fundamentals ratios updated end of day